Heerlen, The Netherlands -- Royal DSM NV and Roquette Freres announced 27 June that they are to jointly make and market bio-based succinic acid, through a new joint venture company, Reverdia Vof, headquartered in the Netherlands.
This venture follows successful cooperation between DSM and Roquette since early 2008 on developing the best, most sustainable fermentation technology to produce bio-based succinic acid.
Test volumes of this renewable and versatile chemical building block -- used in the manufacture of polymers, resins and many other products -- have been produced at a demonstration plant in Lestrem, France, built in 2009.
Positive results from this cooperation led to the set up of Reverdia, with each partner having a 50 percent stake.
Noting the world's dependency on fossil fuels, Volkert Claassen, vice president DSM White Biotechnology, commented: "One day we need alternative sources anyway, but soon it will become economically attractive due to increasing oil prices and - on top of this - alternatives are more environmentally friendly."
DSM and Roquette believe that fermentation-based succinic acid will be able to replace existing fossil based succinic acid, and open new applications, while at the same time delivering a better environmental performance.
Many companies have already sampled and tested bio-based succinic acid from the demonstration plant and intend to take shipments when the plant is running.
The joint venture, which is subject to regulatory approvals, plans to focus on applications such as 1,4 butanediol (BDO), polyurethane resins, and biopolymers such as polybutylene succinate (PBS), for applications in paints and coatings, automotive and textiles.